Invasive group B Streptococcus isolates showing reduced susceptibility to penicillin in Hong Kong [5]

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 6, 2007, Pages 1407-1409

  Chu, Yiu Wai ^a   Tse, Cindy ^b   Tsang, Grand K L ^a   So, Daniel K S ^a   Fung, John T L ^a   Lo, Janice Y C ^a  

^a Public Health Laboratory Services Branch   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

Author keywords

Benzylpenicillin; Blood culture; Penicillin G; Streptococcus agalactiae

Indexed keywords

BETA LACTAMASE; CEFOTAXIME; CLINDAMYCIN; ERYTHROMYCIN; NITROCEFIN; PENICILLIN BINDING PROTEIN; PENICILLIN G; TETRACYCLINE; VANCOMYCIN;

ACCURACY; ADULT; ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CASE REPORT; CONTROLLED STUDY; DIFFUSION; DILUTION; GENE MUTATION; HONG KONG; HUMAN; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATIENT MONITORING; SEROTYPING; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BLOOD; CULTURE MEDIA; FEMALE; HONG KONG; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN RESISTANCE; PENICILLINS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 36448974510     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm390     Document Type: Letter

References (11)

1. Colford JM, Mohle-Boetani J, Vosti KL. Group B streptococcal bacteremia in adults. Five years' experience and a review of the literature. Medicine (Baltimore) 1995; 74: 176-90.
2. Huang PY, Lee MH, Yang CC et al. Group B streptococcal bacteremia in non-pregnant adults. J Microbiol Immunol Infect 2006; 39: 237-41.
3. Stylianopoulos A, Kelly N, Garland S. Is penicillin and/or erythromycin resistance present in clinical isolates of group B Streptococcus in our community? Aust N Z J Obstet Gynaecol 2002; 42: 543-4.
4. de Azavedo JC, McGavin M, Duncan C et al. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B Streptococcus isolates from Ontado, Canada. Antimicrob Agents Chemother 2001; 45: 3504-8.
5. Betriu C, Gomez M, Sanchez A et al. Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrob Agents Chemother 1994; 38: 2183-6.
6. Morikawa Y, Kitazato M, Katuskawa C et al. Prevalence of cefotaxime resistance in group B Streptococcus from Osaka, Japan. J Infect Chemother 2003; 9: 131-3.
7. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Seventeenth Informational Supplement M100-S17. CLSI, Wayne, PA, USA, 2007.
8. Ip M, Cheuk ES, Tsui MH et al. Identification of a Streptococcus agalactiae serotype III subtype 4 clone in association with adult invasive disease in Hong Kong. J Clin Microbiol 2006; 44: 4252-4.
9. Tazi A, Reglier-Poupet H, Raymond J et al. Comparative evaluation of VITEK 2 for antimicrobial susceptibility testing of group B Streptococcus. J Antimicrob Chemother 2007; 59: 1109-13.
10. Kimura K, Wachino J, Kurokawa H et al. Emergence of penicillin-resistant group B streptococci. In: Abstracts of the Forty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 2006. Abstract C2-1286, p. 128. American Society for Microbiology, Washington, DC, USA.
11. Lachenauer CS, Kasper DL, Shimada J et al. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J Infect Dis 1999; 179: 1030-3.